MARIANNE CALL: Open Payments
NPI 1619224110 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,685 in 104 payments from 20 companies in 2025. Trend: 2023 $2,980 · 2024 $1,890 · 2025 $3,685
Food & beverage: $3,685
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $505 |
| AstraZeneca Pharmaceuticals LP | 3 | $368 |
| Alkermes, Inc. | 10 | $354 |
| Otsuka America Pharmaceutical, Inc. | 10 | $339 |
| Janssen Pharmaceuticals, Inc | 9 | $289 |
| ABBVIE INC. | 15 | $258 |
| GENZYME CORPORATION | 2 | $235 |
| E.R. Squibb & Sons, L.L.C. | 7 | $188 |
| Medtronic, Inc. | 1 | $151 |
| Alexion Pharmaceuticals, Inc. | 1 | $135 |
Products named: REXULTI, AUSTEDO XR, SPRAVATO, VRAYLAR, ARISTADA, DUPIXENT, COBENFY, UZEDY.
Industry payments across LA — which companies pay providers there.
